Mark Hooper was appointed Managing Director of Sigma Pharmaceuticals in 2010 and Chair of the NPSA in 2015. Mark has a broad range of experience in finance, commercial and operational matters primarily in the mining and pharmaceutical industries, and is the former Chief Financial Officer (CFO) and Executive Director of PaperlinX Limited. From 2006 to 2008 Mark was the CFO and Chief Operating Officer for the pharmacy and consumer business for Symbion Health, and from 2001 to 2006 was the CFO of Sigma.

Chair/National Pharmaceutical Services Association (NPSA) & CEO, Sigma Healthcare

MARK HOOPER

Session:

The Panel: State of the Industry

When:

Proudly sponsored by:

© 2022 APP Conference. All Rights Reserved.

The 2022 Australian Pharmacy Professional Conference is proudly sponsored by: